Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
I also believe they are withholding price sensitive information, because I refuse to believe that they don't actually have the full data from the Covid trial !
The bad news, is that they keep setting themselves deadlines and keep missing them ! You only have to look at the share price to realise that sentiment is rock bottom !
I just don't understand why they keep setting themselves up to fail, it makes no sense at all.
They over promise and under deliver, not a good combination
Agreed, we were also promised further Covid data a couple of weeks, and then a few weeks from the initial data...
I now make it 7 weeks since top line data, it's absolutely ridiculous and it's the reason that no matter the next few months bring, I won't be holding this for much longer.
Awful comms
yes, I use IG and nothing in my account yet !
Hi Green,
I'm not too worried about Accustem and like you I can't quite decide on what is causing the delay.
On the Covid data, we had a few mixed messages in terms of length of time. i'm sure I heard/read 2 weeks, then a few weeks. Well it has now been 4 weeks, and we still wait.
Anyway, I had some money become available in my SIPP today, so really couldn't turn down 109 this morning !
I don't like to bash a share that i'm invested in, but Davey is right !
Very poor this, even the 2nd set of Covid data was promised and and has been missed
He was talking about Tiziana share price when he said that though, and any sale would not involve Tiziana
The only thing they mentioned was an issue with ADR and then stated they could not discuss further...
Hopefully someone with more knowledge of this can advise, but I don't see why they couldn't give more in depth information about what the issue actually is, surely they are not bound by secrecy over issues with ADR, surely they could have put some more meat on the bone?
The way they skirted around the question got me thinking that they could be in talks to sell. I know i'm probably getting ahead of myself, but it was fairly obvious that she did not want to give too much away. If it was only ADR issue, I don't see why she would be so evasive. Thoughts ?
Greens- No he didn't elaborate on it, it was almost an off the cuff remark. He was talking about MS and Crohns phase 2 and then said something like " we could see a catalyst in a few weeks"
Once recording available, I think it would be good to do a full write up of the Q&A to stick up on here...
You're welcome, apologies again for the spellings, hopefully it all makes sense.
Start wasn't great, but really pleased with some if the responses to the questions...
I feel a lot better after that !
End of 2021 is going to be great, the end !!!!!
Q. Why should we invest in Tiziana
A. Look at the team, we have experience of concept to market drugs. If one of our drugs goes to market, its a game changer (my words, nit the goid Drs)
Q. Why share price dropping
A. I understand concerns and I'm frustrated, everything on track, no bad news, stock market beyond his control. I assure you no negative news
Q. Can covid be fast tracked?
A. Yes but need larger trial with severe patients
Q. Will our patent generate revenue.
A. Patent covers combinations and our anti body. Yes could be source of revenue
Q. Design of MS and Crohns trial 2. And other covid competitors
A. Crohn in US and Europe. Us enrolment slow. So mire in Europe. Total patients 60. Data end 2021.
MS in US, with Harvard medical school. Weiner in charge. 45 patients. Documents with FDA, start hopefully very soon.
Covid. We are first and patented.
Q. Insider ownership
A. Answered by Keiren, no answer, check website
Q. Could Foramulab be fast tracked because of safety profile.
A. Need larger trial, which is uocoming